Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.
AuthorsCromme, F V
Heemels, M T
Ploegh, H L
Keating, P J
Stern, Peter L
Meijer, C J
Walboomers, J M
AffiliationDepartment of Pathology, Free University Hospital, Amsterdam, The Netherlands.
MetadataShow full item record
AbstractMalignant tumor cells can escape CD8+ cytotoxic T cell killing by downregulating class I major histocompatibility complex (MHC) expression. Stable class I MHC surface expression requires loading of the heavy chain/light chain dimer with antigenic peptide, which is delivered to class I MHC molecules in the endoplasmic reticulum by the presumed peptide transporter, encoded by the transporter associated with antigen presentation (TAP) 1 and 2 genes. We have investigated whether loss of class I MHC expression frequently observed in different cancers could result from interference with TAP function. A polyclonal antiserum, raised against a bacterial glutathione S-transferase/human TAP-1 fusion protein, was used for the immunohistochemical analysis of TAP-1 expression in 76 cervical carcinomas. Results showed loss of TAP-1 expression in neoplastic cells in 37 out of 76 carcinomas. Immunohistochemical double staining procedures in combination with HLA-specific antibodies revealed congruent loss at the single cell level of TAP-1 and HLA-A/B expression in 28 out of 37 carcinomas. The remaining samples expressed HLA(-A) in the absence of TAP-1 (n = 6) or showed loss of HLA(-A/B) while TAP-1 was expressed (n = 3). These data strongly indicate that inhibition of peptide transport by downregulation of TAP-1 is a potential strategy of malignant cells to evade immune surveillance.
CitationLoss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. 1994, 179 (1):335-40 J. Exp. Med.
JournalThe Journal of Experimental Medicine
- Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours.
- Authors: Cromme FV, van Bommel PF, Walboomers JM, Gallee MP, Stern PL, Kenemans P, Helmerhorst TJ, Stukart MJ, Meijer CJ
- Issue date: 1994 Jun
- Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
- Authors: Rowe M, Khanna R, Jacob CA, Argaet V, Kelly A, Powis S, Belich M, Croom-Carter D, Lee S, Burrows SR
- Issue date: 1995 May
- Expression and function of the peptide transporters in escape variants of human renal cell carcinomas.
- Authors: Seliger B, Höhne A, Jung D, Kallfelz M, Knuth A, Jaeger E, Bernhard H, Momburg F, Tampé R, Huber C
- Issue date: 1997 Jul
- Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.
- Authors: Korkolopoulou P, Kaklamanis L, Pezzella F, Harris AL, Gatter KC
- Issue date: 1996 Jan
- Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression.
- Authors: Seliger B, Höhne A, Knuth A, Bernhard H, Ehring B, Tampé R, Huber C
- Issue date: 1996 Aug